Literature DB >> 10070267

Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity.

V Agnello1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10070267      PMCID: PMC1752515          DOI: 10.1136/ard.57.12.701

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  11 in total

1.  Characterization of cryoglobulins by immunoblotting.

Authors:  L Musset; M C Diemert; F Taibi; L Thi Huong Du; P Cacoub; J M Leger; G Boissy; O Gaillard; J Galli
Journal:  Clin Chem       Date:  1992-06       Impact factor: 8.327

2.  Immune complexes and disease. General introduction.

Authors:  H G Kunkel
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

3.  Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

Authors:  M Meltzer; E C Franklin; K Elias; R T McCluskey; N Cooper
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

4.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

5.  Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection.

Authors:  Y H Lee; J D Ji; J E Yeon; K S Byun; C H Lee; G G Song
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

Review 6.  The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias.

Authors:  G Monti; M Galli; F Invernizzi; P Pioltelli; F Saccardo; A Monteverde; M Pietrogrande; P Renoldi; S Bombardieri; G Bordin
Journal:  QJM       Date:  1995-02

8.  A role for hepatitis C virus infection in type II cryoglobulinemia.

Authors:  V Agnello; R T Chung; L M Kaplan
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

9.  Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia.

Authors:  V Agnello; G Abel
Journal:  Arthritis Rheum       Date:  1997-11

10.  Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

Authors:  F Lunel; L Musset; P Cacoub; L Frangeul; P Cresta; M Perrin; P Grippon; C Hoang; D Valla; J C Piette
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

View more
  4 in total

1.  Whole-blood hepatitis C virus RNA extraction methods.

Authors:  W Schmidt; J T Stapleton
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.

Authors:  P Lamprecht; F Moosig; A Gause; K Herlyn; E Csernok; H Hansen; W L Gross
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 3.  Extrahepatic manifestations of hepatitis C infection: navigating CHASM.

Authors:  Amy C Sherman; Kenneth E Sherman
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

Review 4.  Systemic manifestations of hepatitis C infection.

Authors:  Lydia Tang; Lauren Marcell; Shyam Kottilil
Journal:  Infect Agent Cancer       Date:  2016-05-23       Impact factor: 2.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.